ROI

A landmark Japan-US partnership aims to solve AI's credibility crisis, deploying defense-vetted, verifiable AI into the world's most critical infrastructure.

Otto Aerospace's Phantom 3500 just passed a major FAA milestone, but this is more than paperwork. It's a blueprint for certifying radical aviation tech.

A new report finds GTM leaders are prioritizing speed to revenue, yet face a major paradox: the fragmented technologies and uncertain AI meant to help are slowing them down.

Pushpay's new integration with Nurture.io isn't just a software update; it's a blueprint for how data can foster genuine human connection at scale.

A new generation of men is shattering the stigma around mental health at work, but a startling retention gap reveals a deeper crisis for employers.

Homeowners are tapping equity at the highest Q1 rate since 2021, not by refinancing, but through a surge in second liens not seen in two decades.

As National Outlet Shopping Day returns, it's more than a sale. It's Simon's blueprint for the future of retail and a key test of consumer spending.

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

How new high-resolution analysis at Canadian GoldCamps' flagship project is de-risking a complex deposit and revealing its true high-grade potential.

With its new biomimetic DexHand and massive funding, TARS isn't just building a robot hand. It's aiming to bridge the gap between AI and the physical world.

At Shanghai's CHINA CYCLE expo, CST Tires unveiled more than just lightweight tech; it showcased a strategic pivot that could redefine global manufacturing.

The 10-year extension for the Las Vegas Grand Prix is more than a race deal; it's a high-stakes maneuver cementing F1's US strategy amid local growing pains.

As AI and crypto converge, a new project bets its future not on speculation, but on tangible utility and verifiable security. We deconstruct the model.

Canada's new 'AI for All' strategy bets billions on sovereign compute and closing its adoption gap. Can this ambitious plan build a uniquely Canadian AI future?

DXRacer's exclusive chairs for Dead by Daylight's anniversary are not for sale. Here's the real value behind a priceless marketing maneuver.

AM Best affirms Victoria Insurance's 'Good' rating despite a shrinking footprint, revealing a high-stakes balancing act between a fortress balance sheet and immense market risks.

With the approval of its advanced cancer drug Eratrectinib, Vcare PharmaTech challenges global rivals, showcasing China's AI-driven R&D and strategic ambition.

As Florida celebrates National Homeownership Month, the dream of owning a home clashes with a perfect storm of insurance crises and affordability challenges.

A new firm offers up to $250k in funded accounts for prediction market traders, a move that could professionalize a booming sector. But can it navigate the complex regulatory field?

Amid a regional healthcare crisis, 475 nurses at BMC South plan to picket, citing unsafe staffing and a 'bullying' contract offer from management.